Piloting Pathways With Lung Cancer Patients

Laurie McLouth

Status: Completed

Conditions: Metastatic Lung Cancer

Treatments: Behavioral: Pathways

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT04161157

52168

R03CA235171-01A1 (U.S. NIH Grant/Contract)

Details and patient eligibility

About

The purpose of this research is to determine the feasibility of a new supportive intervention, called Pathways, for patients with advanced stage and metastatic lung cancer.

Full description

In this study, investigators will first test the Pathways procedures with 6 patients to identify any improvements that need to be made. Then, investigators will test the feasibility of the Pathways intervention with 20 patients who are undergoing cancer treatment for advanced stage or metastatic lung cancer. Pathways is designed to help patients set and pursue personal goals during lung cancer treatment. In this study, investigators want to see if they can recruit patients with lung cancer who are being treated at the University of Kentucky Markey Cancer Center to participate in the Pathways intervention.

Enrollment: 53 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• new or recurrent stage IIIB, stage IIIC or stage IV non-small cell lung cancer (NSCLC) or extensive stage SCLC
• 18 years of age or older
• ECOG PS 0-2/Karnofsky 60-100
• 3 to 12 weeks into active cancer treatment

Exclusion criteria

• unstable brain metastases
• cognitive or psychiatric condition for which participating would be inappropriate
• unable to speak and read English

Trial design

Primary purpose: Supportive Care

Allocation: N/A

Interventional model: Single Group Assignment

Masking: None (Open label)

---

53 participants in 1 patient group

Pathways

Experimental group

Description:

Pathways is designed to help patients identify and pursue values-based goals and address potential goal obstacles, including lung cancer stigma.

Treatment:

Behavioral: Pathways